UnitedHealth Group Incorporated $UNH Stake Decreased by Onyx Bridge Wealth Group LLC

Onyx Bridge Wealth Group LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 661 shares of the healthcare conglomerate’s stock after selling 227 shares during the period. Onyx Bridge Wealth Group LLC’s holdings in UnitedHealth Group were worth $206,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in UNH. Bayforest Capital Ltd increased its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the period. Kentucky Trust Co increased its stake in shares of UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after acquiring an additional 50 shares during the period. O Brien Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after acquiring an additional 37 shares during the period. Finally, Cloud Capital Management LLC acquired a new position in shares of UnitedHealth Group during the first quarter valued at approximately $53,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.1%

NYSE UNH opened at $361.29 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $327.21 billion, a price-to-earnings ratio of 15.65, a PEG ratio of 2.36 and a beta of 0.47. The firm’s 50 day moving average price is $335.48 and its two-hundred day moving average price is $341.42.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. The company’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target on the stock. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Barclays lifted their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, KeyCorp lifted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.